Sanofi and Bristol gain EU support for wider approval of Plavix

11/21/2010 | Reuters

Bristol-Myers Squibb and Sanofi-Aventis have obtained the European Medicines Agency's endorsement to use anti-clotting drug Plavix for the prevention of thromboembolic and atherothrombotic events in certain adults with atrial fibrillation.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA